Right, like most organizations these companies don’t want to be the mole that pops its head up and gets whacked

I wish people understood just how f*cked the academia-to-industry pipeline is at every step research activity, training, targets, startups, acquisitions, investment there’s severe ischemia swiftly becoming an infarct the long term debilitation will haunt us